Food Allergy in Children Clinical Trial
Official title:
Multicenter, Open, Controlled, Randomized Study to Evaluate the Efficacy of the OITcontrol Application in Monitoring Patients in OIT With Food.
Verified date | November 2022 |
Source | Clinica Universidad de Navarra, Universidad de Navarra |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main aim of this study is to evaluate the clinical efficacy of the OITcontrol application in patients undergoing OIT of eggs or milk used during the follow-up of this treatment.
Status | Completed |
Enrollment | 104 |
Est. completion date | September 30, 2023 |
Est. primary completion date | September 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 4 Years to 12 Years |
Eligibility | Inclusion Criteria: - The patient must be between 4 and 12 years old at the time of informed consent. - Patients diagnosed with food allergy to eggs and/or milk (clinical history compatible with IgE-mediated reaction with egg or milk together with positive specific IgE against egg white or milk (>0.35kU/L) and/or skin test by intraepidermal puncture equal to or similar to 3mm for egg white or milk); in case of egg allergy, patients may be allergic to raw or undercooked egg despite their tolerance to well-cooked egg. - The patient, or their legally authorized representative, has given their consent to participate in the study. - The patient, or his legally authorized representative, has accepted the OIT treatment after the explanation of its risks and benefits and the requirements for the maintenance phase. - The patient must, in the opinion of the investigator, be able to meet all the requirements of the study. - The patient, or their legally authorized representative, who assumes the OIT treatment at home, has a Smartphone with internet access via mobile data and/or Wi-Fi available at home. - Reaction with the OIT allergen in the controlled oral provocation test (POC) included in the initial phase of treatment. Exclusion Criteria: - Present any of the OIT exclusion criteria: 1. Allergy to cow's milk and/or eggs not mediated by IgE. 2. Uncontrolled asthma. In the case of a patient with asthma, this must be controlled before the start of OIT. 3. Severe atopic dermatitis. 4. Previous diagnosis of eosinophilic esogaphitis. 5. Inflammatory bowel disease. 6. Mastocytosis. 7. Immunocompromised patients. 8. Disorders and/or treatments in which the use of adrenaline is contraindicated. 9. Difficulty understanding the risks and benefits of the procedure, and social and family factors that may compromise long-term maintenance therapy. This includes conflicts between parents or legal representatives that may adversely affect treatment. 10. Inability of parents or legal representative to follow instructions, identify reactions, or administer medication (especially auto-injectable adrenaline). - Previous allergic reaction with the corresponding OIT food within the month prior to the initial visit. - Treatment with omalizumab or any other immunomodulatory biologic drug within the three months prior to the initial visit. - Pregnant women, or women of childbearing potential not using a safe means of contraception (abstinence is considered an acceptable method) during the entire study period. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Fundación Alcorcón | Alcorcón | Madrid |
Spain | Hospital Severo Ochoa | Leganés | Madrid |
Spain | Hospital Clínico San Carlos | Madrid | |
Spain | Hospital Gregorio Marañón | Madrid | |
Spain | Hospital Infanta Leonor | Madrid | |
Spain | Hospital Universitario Ramón y Cajal | Madrid | |
Spain | Universidad de Navarra | Pamplona | Navarra |
Lead Sponsor | Collaborator |
---|---|
Clinica Universidad de Navarra, Universidad de Navarra |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The effectiveness of OITcontrol as an application to improve the quality of life. | Improve the quality of life of patients, as well as their perception of the quality and safety of hospital care, safety and the reduction of the consumption of health resources in patients under OITcontrol.
Baseline variables of the patient's clinical history in relation to their allergy to the allergen in the OIT, their base treatment and/or premedication, and the baseline sensitization parameters (skin test, total and specific IgE to the allergen of the OIT) obtained in the V0. The variables of the first day of treatment will be collected: threshold dose, last tolerated dose, and type of reaction presented. The variables in the escalation visits will be taken in the space of time between two hospital visits. The data to be collected in a hospital visit correspond to the events that occurred during that hospital visit and in the home doses or extraordinary hospital visits of the previous week from the last ordinary hospi |
12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05839405 -
Food Allergy in the Brain
|
||
Completed |
NCT04378335 -
Assessment of Orality Disorders in Children With Food Allergies
|
N/A | |
Recruiting |
NCT03776474 -
Determine Immunoglobulin G4 (IgG4) Standards for Cow's Milk and Egg in Different Populations of Allergic and Non-allergic Children
|
||
Active, not recruiting |
NCT05165329 -
A Randomized, Controlled Trial of Probiotic and Peanut Oral Immunotherapy (PPOIT) in Inducing Tolerance in Hong Kong Children With Peanut Allergy Compared With Oral Immunotherapy (OIT) Alone and With Placebo
|
N/A | |
Completed |
NCT05093114 -
Friends, Family & Food: Food Allergy App for Youth ( F3A-App )
|
||
Recruiting |
NCT05406141 -
Nutrition Sufficiency, Allergy Efficacy and Safety of Neocate Jr in Children With Food Protein Allergy
|
N/A | |
Completed |
NCT05111938 -
Friends, Family & Food: Food Allergy App for Youth - II
|
N/A | |
Recruiting |
NCT06034678 -
Evaluation of The Food Allergy Mastery Program
|
N/A | |
Recruiting |
NCT06467994 -
Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children
|
Phase 2 | |
Not yet recruiting |
NCT04407104 -
Allergy to Almond in Children
|
||
Enrolling by invitation |
NCT05287074 -
The Significance of a Timely Food Allergy Diagnosis and Optimal Surveillance of Nutritional Status in Children
|
||
Enrolling by invitation |
NCT04955132 -
Impact of E-learning on Parental Confidence in Managing Food Allergy
|
N/A | |
Active, not recruiting |
NCT05590299 -
Fish Oral Immunotherapy in Hong Kong Children
|
N/A | |
Recruiting |
NCT03309488 -
Basophil Activation Test to Diagnose Food Allergy
|
||
Recruiting |
NCT05707858 -
The Naples Pediatric Food Allergy (NAPFA) Score
|
||
Suspended |
NCT04198753 -
Skin Characteristics of Parents of Food Allergic Pediatric Patients
|
||
Recruiting |
NCT05309772 -
The Clinical Impact of the Basophil Activation Test to Diagnose Food Allergy
|
N/A | |
Recruiting |
NCT04376242 -
Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge
|
N/A | |
Completed |
NCT04770727 -
CBT Group Intervention for Children With Food Allergy and Anxiety
|
N/A | |
Completed |
NCT04512924 -
The Psychosocial Outcomes in Caregivers of Children With Food Allergy
|
N/A |